Tradewinds Capital Management’s Abiomed Inc ABMD Stock Holding History

Tradewinds Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90	Closed	-$15K	–	767
2019 Q4	$15K	Hold	90	–	–	﹤0.01%	351
2019 Q3	$16K	Hold	90	–	–	0.01%	309
2019 Q2	$23K	Hold	90	–	–	0.01%	258
2019 Q1	$26K	Hold	90	–	–	0.01%	255
2018 Q4	$29K	Hold	90	–	–	0.01%	233
2018 Q3	$40K	Hold	90	–	–	0.02%	240
2018 Q2	$37K	Hold	90	–	–	0.02%	248
2018 Q1	$26K	Hold	90	–	–	0.01%	264
2017 Q4	$17K	Hold	90	–	–	0.01%	348
2017 Q3	$15K	Hold	90	–	–	0.01%	349
2017 Q2	$13K	Sell	90 -14	-13%	-$1.88K	0.01%	364
2017 Q1	$13K	Buy	104 +90	+643%	+$10.4K	0.01%	367
2016 Q4	$2K	Hold	14	–	–	﹤0.01%	577
2016 Q3	$2K	Hold	14	–	–	﹤0.01%	585
2016 Q2	$2K	Hold	14	–	–	﹤0.01%	577
2016 Q1	$1K	Hold	14	–	–	﹤0.01%	615
2015 Q4	$1K	Hold	14	–	–	﹤0.01%	624
2015 Q3	$1K	Hold	14	–	–	﹤0.01%	609
2015 Q2	$1K	Hold	14	–	–	﹤0.01%	644
2015 Q1	$1K	Buy	+14	New	+$760	﹤0.01%	589

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Tradewinds Capital Management's ABMD Position: Q1 2020 in Review

Tradewinds Capital Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 90 shares — an estimated $15K sold.

Tradewinds Capital Management first reported a position in ABMD in Q1 2015 and held it in 20 quarters. The position peaked at $40K in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

Tradewinds Capital Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
Tradewinds Capital Management sold 90 Abiomed Inc shares in Q1 2020, an estimated $15K.
Tradewinds Capital Management first reported a position in Abiomed Inc in Q1 2015 and held it in 20 quarters.
Tradewinds Capital Management's Abiomed Inc position peaked at $40K in Q3 2018.
412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Tradewinds Capital Management's 13F filing for Q1 2020, filed 11 May 2020.